• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Submit your nominations for the Fierce Innovation Awards - Entries close this Friday

antisense

Ionis headquarters
Favicon Fierce Pharma

Ionis scores ‘breakthrough’ rare disease approval

The FDA has approved Ionis' Zanvastro, the first medicine for Alexander disease and a first step in Ionis' journey to building a solo neuro franchise.
Darren Incorvaia Sep 4, 2026 11:18am
Pipette dripping water droplet with money symbol on it into test tube

AusperBio adds $120M series C to push hep B drug through ph. 3

Aug 28, 2026 10:26am
Brain scan neuroscience

AAIC: Biogen bolsters hopes for pivotal anti-tau push

Jul 14, 2026 9:15am
Brain and money connected by a thread on a white background

Ionis bags $30M from Recordati for ex-US rare disease rights

Jun 25, 2026 6:59am
positive negative up down good bad mixed

Biogen advances Alzheimer’s tau program despite midphase miss

May 14, 2026 8:35am
Link

Biogen links up with Alloy platform to boost ASO drug development

Apr 7, 2026 6:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings